"Rilpivirine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A diarylpyrimidine derivative and REVERSE TRANSCRIPTASE INHIBITOR with antiviral activity against HIV-1 that is used in the treatment of HIV INFECTIONS. It is also used in combination with other ANTI-HIV AGENTS, since ANTIVIRAL DRUG RESISTANCE emerges rapidly when it is used alone.
| Descriptor ID |
D000068696
|
| MeSH Number(s) |
D02.626.809 D03.383.742.755
|
| Concept/Terms |
TMC 278- TMC 278
- 278, TMC
- TMC278
- TMC-278
|
Below are MeSH descriptors whose meaning is more general than "Rilpivirine".
Below are MeSH descriptors whose meaning is more specific than "Rilpivirine".
This graph shows the total number of publications written about "Rilpivirine" by people in this website by year, and whether "Rilpivirine" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2024 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Rilpivirine" by people in Profiles.
-
Safety and pharmacokinetics of oral and long-acting injectable cabotegravir or long-acting injectable rilpivirine in virologically suppressed adolescents with HIV (IMPAACT 2017/MOCHA): a phase 1/2, multicentre, open-label, non-comparative, dose-finding study. Lancet HIV. 2024 Apr; 11(4):e211-e221.
-
Rilpivirine inhibits SARS-CoV-2 protein targets: A potential multi-target drug. J Infect Public Health. 2021 Oct; 14(10):1454-1460.
-
Cost-effectiveness of Injectable Preexposure Prophylaxis for HIV Prevention in South Africa. Clin Infect Dis. 2016 08 15; 63(4):539-47.